These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 7617209)

  • 1. HLA antigens in severe forms of Guillain-Barré syndrome.
    Piradov MA; Dolbin AG; Voylokova RYa ; Yazdovsky VV
    Neurology; 1995 Jul; 45(7):1419-20. PubMed ID: 7617209
    [No Abstract]   [Full Text] [Related]  

  • 2. HLA typing and Guillain-Barré syndrome.
    Latovitzki N; Suciu-Foca N; Penn AS; Olarte MR; Chutorian AM
    Neurology; 1979 May; 29(5):743-5. PubMed ID: 571573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA antigens in Guillain-Barré syndrome.
    Kaslow RA; Sullivan-Bolyai JZ; Hafkin B; Schonberger LB; Kraus L; Moore MJ; Yunis E; Williams RM
    Neurology; 1984 Feb; 34(2):240-2. PubMed ID: 6538019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA antigens in the Guillain-Barré syndrome.
    Winer JB; Briggs D; Welsh K; Hughes RA
    J Neuroimmunol; 1988 Apr; 18(1):13-6. PubMed ID: 2831249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-antigens in Guillain-Barré syndrome.
    Hafez M; Nagaty M; Al-Tonbary Y; el-Shennawy FA; el-Mongui A; el-Sallab S; Attia S
    J Neurogenet; 1985 Sep; 2(4):285-90. PubMed ID: 4087075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological observations in Guillain-Barré syndrome.
    Sepcić J; Morović M; Rukavina D; Sepić-Grahovac D
    Acta Med Iugosl; 1990; 44(4):265-74. PubMed ID: 2091432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA antigens in the Landry-Guillain-Barré syndrome and chronic relapsing polyneuritis.
    Stewart GJ; Pollard JD; McLeod JG; Wolnizer CM
    Ann Neurol; 1978 Sep; 4(3):285-9. PubMed ID: 718142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guillain-Barré syndrome after varicella-zoster infection. Case report.
    Arruda WO; Aguiar LR; Sandoval PR
    Arq Neuropsiquiatr; 1987 Dec; 45(4):430-3. PubMed ID: 3449027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-DR antigens in Mexican patients with Guillain-Barré syndrome.
    Gorodezky C; Varela B; Castro-Escobar LE; Chávez-Negrete A; Escobar-Gutiérrez A; Martínez-Mata J
    J Neuroimmunol; 1983 Feb; 4(1):1-7. PubMed ID: 6401765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA antigens in familial Guillain-Barré syndrome.
    Davidson DL; O'Sullivan AF; Morley KD
    J Neurol Neurosurg Psychiatry; 1992 Jun; 55(6):508-9. PubMed ID: 1619424
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies of HLA associations in male and female patients with Guillain-Barré syndrome (GBS) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP).
    McCombe PA; Csurhes PA; Greer JM
    J Neuroimmunol; 2006 Nov; 180(1-2):172-7. PubMed ID: 16935351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The frequencies of Killer immunoglobulin-like receptors and their HLA ligands in chronic inflammatory demyelinating polyradiculoneuropathy are similar to those in Guillian Barre syndrome but differ from those of controls, suggesting a role for NK cells in pathogenesis.
    Blum S; Csurhes P; McCombe P
    J Neuroimmunol; 2015 Aug; 285():53-6. PubMed ID: 26198918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Recurrent polyradiculoneuritis: report of 2 cases].
    Marchiori PE; Scaff M; Callegaro D; Zambon AA; de Assis JL
    Arq Neuropsiquiatr; 1983 Jun; 41(2):208-11. PubMed ID: 6639405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guillain-Barré syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies.
    Ho TW; Mishu B; Li CY; Gao CY; Cornblath DR; Griffin JW; Asbury AK; Blaser MJ; McKhann GM
    Brain; 1995 Jun; 118 ( Pt 3)():597-605. PubMed ID: 7600081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential distribution of HLA alleles in two forms of Guillain-Barré syndrome.
    Monos DS; Papaioakim M; Ho TW; Li CY; McKhann GM
    J Infect Dis; 1997 Dec; 176 Suppl 2():S180-2. PubMed ID: 9396707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathology of the motor-sensory axonal Guillain-Barré syndrome.
    Griffin JW; Li CY; Ho TW; Tian M; Gao CY; Xue P; Mishu B; Cornblath DR; Macko C; McKhann GM; Asbury AK
    Ann Neurol; 1996 Jan; 39(1):17-28. PubMed ID: 8572662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-GM1 IgG antibodies and Campylobacter bacteria in Guillain-Barré syndrome: evidence of molecular mimicry.
    Oomes PG; Jacobs BC; Hazenberg MP; Bänffer JR; van der Meché FG
    Ann Neurol; 1995 Aug; 38(2):170-5. PubMed ID: 7654064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated serum levels of tumor necrosis factor-alpha in Guillain-Barré syndrome.
    Sharief MK; McLean B; Thompson EJ
    Ann Neurol; 1993 Jun; 33(6):591-6. PubMed ID: 8498839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetics of Guillain-Barré syndrome (GBS) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): current knowledge and future directions.
    Blum S; McCombe PA
    J Peripher Nerv Syst; 2014 Jun; 19(2):88-103. PubMed ID: 25039604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A patient with Guillain-Barré syndrome in association with Campylobacter jejuni enteritis (PEN19:LIO7) in a patient with HLA-B52 antigen].
    Kaida K; Yuki N; Takahashi M; Kamakura K; Nagata N
    Rinsho Shinkeigaku; 1994 Jul; 34(7):733-5. PubMed ID: 7955736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.